期刊文献+

甲巯咪唑致肝损伤、皮疹及关节炎综合征 被引量:5

Methimazole caused liver damage, rash and arthritis syndrome
原文传递
导出
摘要 1例29岁女性患者因甲状腺功能亢进遵医嘱口服甲巯咪唑20 mg、1次/d,用药前肝功能正常.用药14 d后,患者血清ALT 122 U/L,AST 87 U/L,停用甲巯咪唑并予保肝治疗.9 d后,患者ALT 42 U/L,AST 35 U/L,遵医嘱再次口服甲巯咪唑片10 mg、1次/d.再次用药第9天,患者全身出现皮疹伴瘙痒,右肘关节疼痛、活动受限,双肩关节及膝关节疼痛,实验室检查示ALT 134 U/L,AST 109 U/L,诊断为药物性肝损伤、药物性皮疹和药物相关关节炎综合征.再次停用甲巯咪唑,给予抗过敏、保肝及止痛治疗.10 d后,患者皮疹基本消退,ALT 36 U/L,AST 24 U/L,关节疼痛稍有改善,可自主活动,偶有活动受限. A 29-year-old female patient with hyperthyroidism received methimazole 20 mg once daily according to the doctor′s advice. Her liver function was normal before drug administration. Fourteen days after medication,the results of laboratory test showed that ALT was 122 U/ L,AST 87 U/ L. Methimazole was stopped and liver protection treatment was given. Nine days later,her ALT and AST were 42 U/ L and 35 U/ L,respectively. She received methimazole 10 mg once daily again. On day 9 of remedication,the patient developed rash with pruritus,pain and limitation of activity on the right elbow joint,pain on the bilateral shoulder joints and the knee joints,and laboratory test showed ALT 134 U/ L,and AST 109 U/ L. She was diagnosed as drug induced liver injury,drug rash,and drug related arthritis syndrome. Methimazole was stopped again. The patient received the treatments of antianaphylaxis,liver protection and analgesic. Ten days later,her rash mostly disappeared. Laboratory test showed ALT 36 U/ L and AST 24 U/ L. Her arthralgia was improved slightly,could move intentionally,but activity was limitated occasionally.
出处 《药物不良反应杂志》 CSCD 2017年第6期473-474,共2页 Adverse Drug Reactions Journal
关键词 甲巯咪唑 药疹 药物性肝损伤 关节炎 Methimazole Drug erupsions Drug-induced liver injury Arthritis
  • 相关文献

参考文献6

二级参考文献40

  • 1连小兰,白耀,戴为信,金自孟,曾正陪,郭芝生.丙硫氧嘧啶导致症状性肝损伤的临床特征及相关因素分析[J].中华内科杂志,2004,43(6):442-446. 被引量:22
  • 2郑田芝.胃肠病学[M].3版.北京:人民卫生出版社.2000:308.
  • 3白耀.甲状腺病学-基础与临床[M].北京:科学技术文献出版社,2004.388.
  • 4Davies TF, Larsen PR. Thyrotixicosis// Larsen PR, Kronenberg HM, Melmed S. Wlilliams textbook of endocrinology. 10th ed. Philadelphia: Saunders, 2002: 374-424.
  • 5Chiovato L, Babesino G, Pinchera A. Graves disease//DeGroot LJ, Jameson JL. Endocrinology. 4th ed. Philadelphia: Saunders, 2001 : 1422-1449.
  • 6Greenspan FS. The thyroid gland//Greenspan FS, Gardner DG. Basic and clinical endocrinology. New York: Lange /McGraw- Hill, 2001: 201-272.
  • 7Fisher DA. Disorders of the thyroid in the newborn and infant// Sperling MA. Pediatric endocrinology. 2nd ed. Philadelphia: Sannders, 2002 : 161-186.
  • 8Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med, 2000, 160:1573-1575.
  • 9American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract, 2002,8:457-469.
  • 10Teng W, Shan Z, Teng X, et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med, 2006, 354:2783-2793.

共引文献912

同被引文献37

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部